![P4782Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation]()
P4782Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillationChoi, E.-K; Lee, S R; Lee, S R; Kwon, S; Kwon, S; Han, K D; Han, K D; Jung, J H; Jung, J H; Oh, S; Oh, S; Lip, G Y H; Lip, G Y H · European Heart Journal · 2019